Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways

• Published in: Scientific reports Vol. 11; no. 1; pp. 23194 - 10
• Main Authors: Kobayashi, Hirotada, Amrein, Karin, Lasky-Su, Jessica A., Christopher, Kenneth B.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.12.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 25-Hydroxyvitamin D; 631/250/256/2516; 631/45/320; 631/553/1464; 692/308/2779/777; Aged; Amino acids; Biomarkers; Cholecalciferol - therapeutic use; Critical Illness - therapy; Energy Metabolism - drug effects; Energy utilization; Female; Humanities and Social Sciences; Humans; Immune response; Inflammation; Inflammation - blood; Inflammation - metabolism; Inflammation - therapy; Male; Metabolic Networks and Pathways - drug effects; Metabolic response; Metabolism; Metabolites; Metabolome - drug effects; Metabolomics; Middle Aged; multidisciplinary; Pentose phosphate pathway; Placebo Effect; Procalcitonin; Procalcitonin - blood; Procalcitonin - metabolism; Science; Science (multidisciplinary); Vitamin D3; Vitamins - therapeutic use
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-02679-0

Procalcitonin is a biomarker of systemic inflammation and may have importance in the immune response. The metabolic response to elevated procalcitonin in critical illness is not known. The response to inflammation is vitally important to understanding metabolism alterations during extreme stress. Our aim was to determine if patients with elevated procalcitonin have differences in the metabolomic response to early critical illness. We performed a metabolomics study of the VITdAL-ICU trial where subjects received high dose vitamin D 3 or placebo. Mixed-effects modeling was used to study changes in metabolites over time relative to procalcitonin levels adjusted for age, Simplified Acute Physiology Score II, admission diagnosis, day 0 25-hydroxyvitamin D level, and the 25-hydroxyvitamin D response to intervention. With elevated procalcitonin, multiple members of the short and medium chain acylcarnitine, dicarboxylate fatty acid, branched-chain amino acid, and pentose phosphate pathway metabolite classes had significantly positive false discovery rate corrected associations. Further, multiple long chain acylcarnitines and lysophosphatidylcholines had significantly negative false discovery rate corrected associations with elevated procalcitonin. Gaussian graphical model analysis revealed functional modules specific to elevated procalcitonin. Our findings show that metabolite differences exist with increased procalcitonin indicating activation of branched chain amino acid dehydrogenase and a metabolic shift.